ǥ :
|
ȣ - 470240 198 |
Radiofrequency catheter ablation for ventricular arrhythmia using an electroanatomical mapping system: Comparison with conventional mapping |
Division of Cardiology, Internal Medicine, College of Medicine, Keimyung University, Daegu, Korea |
Hyoung-Seob Park, Yoon-Nyun Kim, Seong-Wook Han, Nam-Min Kang, Yun-Kyeong Cho, Hyuck-Jun Yun, Young-Soo Lee, Dae-Woo Hyun, Seung-Ho Hur, Kee-Sik Kim, Kwon-Bae Kim |
Background: Electroanatomical mapping system (CARTO) is a method that reconstructs a three dimensional map of the heart by sequentially acquiring contacted catheter electrographic data. It improves catheter navigation and the three dimensional display of an arrhythmia mechanism. We report an early experience of radiofrequency catheter ablation (RFCA) for ventricular arrhythmia by electroanatomical mapping(EAM) compared to conventional mapping(CM). Methods and Results: From February 2000 to May 2003, out of twenty five patients(9 male, age 38.9±13.7) who had ventricular arrhythmia, 12 patients underwent conventional mapping guided RFCA(group A) and 13 patients underwent electroanatomical mapping guided RFCA(group B). Average symptom duration was 75.9±86.3 months. EAM was usually done during arrhythmia to acquire an activation map. CM was done using a pace map or activation map depending on the arrhythmia. 5 patients in group B had a history of failed CM guided RFCA. Other results are as follows; Conclusion: In group B, disease entity was more diverse and complex than group A. EAM was found effective guiding RFCA of ventricular arrhythmia. Because EAM was mainly activation time map and because of early experience, mean fluoroscopic time was longer in group B. If experiences were accumulated, the procedure time would be decreased and EAM would be an effective method for RFCA of ventricular arrhythmia.
|
|
CM(n=12) |
EAM(n=13) |
|
CM(n=12) |
EAM(n=13) |
Diagnosis
Idiopathic
VT
Ischemic VT
Symptomatic
PVC
ARVD |
12
(100.0%) |
9
(69.2%)
1
(7.7%)
2
(15.4%)
1
(7.7%) |
Site
LVOT
LV
RVOT
RV |
0
(0.0%)
6
(50.0%)
5
(41.7%)
1
(8.3%) |
1
(7.7%)
3
(23.1%)
7
(53.8%)
2
(15.4%) |
Acute
success rate |
10/12(83.3%) |
11/13(84.6%) |
Follow
up duration(month) |
11.8±14.9 |
5.9±2.9 |
Fluoroscopic
time(min) |
37.1±30.2
|
45.5±28.3 |
Holter
follow
up
No
PVC
Isolated PVC
NSVT |
n =
9
1
(11.1%)
7
(77.8%)
1
(11.1%) |
n =
9
1
(11.1%)
7
(77.8%)
1
(11.1%) |
|
|
|